Cart
sales@molnova.com
Ephedrannin A
CAS No. 82001-39-6
Ephedrannin A( —— )
Catalog No. M32535 CAS No. 82001-39-6
Ephedrannin A has Anti-melanogenesis activity. Ephedrannin A has anti-inflammatory activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 551 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameEphedrannin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionEphedrannin A has Anti-melanogenesis activity. Ephedrannin A has anti-inflammatory activity.
-
DescriptionEphedrannin A has Anti-melanogenesis activity. Ephedrannin A has anti-inflammatory activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82001-39-6
-
Formula Weight556.5
-
Molecular FormulaC30H20O11
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Biochim Biophys Acta . 2015 Jul;1850(7):1389-1396.
molnova catalog
related products
-
DDAO
DDAO is a promising near-infrared (NIR) red fluorescent probe?with long?emission wavelength?(λem?=?656?nm) and tunable excitation wavelength (600-650?nm).
-
Nonapeptide-1
Nonapeptide-1 can inhibit the synthesis of melanin which makes it of interest for treating certain skin conditions.?
-
Milatuzumab
Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.
